Today’s news are covered by the information about Ambit Biosciences Corporation’s price of its initial public offering. They have 8,125,000 shares of its common stock. The price is $8.00 per share. This company has provided a 30-day term to buy up to an additional 1,218,750 shares. This is an initial public offering price. It will cover over-allotments if such takes place.
The managers belong to Citigroup and Leerink Swann. Additionally, BMO Capital Markets is performing as chief manager. Robert W. Baird & Co. Inc. is a co-manager.
This offer is proposed by means of a prospectus. The copies may be acquired from Citigroup Global Markets Inc. or by email or by phone.
This press release shall not contain an offer to sell an offer to buy nor shall there be any sale of these securities in any state or affiliation in which such offer takes place, affiliation or sale would be illegal before registration or qualification under the laws of any such state.